Hepatitis C OnlineLogo
Section Navigation
Common TitleEXPEDITION-1
Official Title Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial.
Phase Phase III
ClinicalTrials.gov NCT02642432
Treatments
Glecaprevir-Pibrentasvir

Glecaprevir-Pibrentasvir

Tradename:MavyretOther Names:GLE-PIBClass:FDA-Approved
Funding
IndustryAbbVie

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.